Invesco Funds Q2 2024 Performance Review: A Comprehensive Analysis

Invesco Rising Dividends Fund: Steady Growth in Dividend-Paying Stocks

The Invesco Rising Dividends Fund demonstrated a focus on companies with consistent dividend growth in Q2 2024. The fund's strategy of investing in stocks with at least 10 years of dividend increases proved effective, with top holdings including Microsoft, Procter & Gamble, and Johnson & Johnson 1

1

. The fund's sector allocation favored Information Technology and Health Care, reflecting a balance between growth potential and stability.

Growth and Income Fund: Balancing Value and Growth

Invesco's Growth and Income Fund maintained its strategy of blending value and growth stocks in Q2 2024. The fund's top holdings included well-established companies like JPMorgan Chase, Bank of America, and Johnson & Johnson 2

2

. With a significant allocation to Financials and Health Care sectors, the fund aimed to capitalize on economic recovery while managing risk.

American Franchise Fund: Focus on High-Quality Growth

The Invesco American Franchise Fund continued its emphasis on high-quality, large-cap growth stocks in Q2 2024. Notable holdings included tech giants like Microsoft, Apple, and Alphabet 3

3

. The fund's sector allocation heavily favored Information Technology and Communication Services, reflecting its growth-oriented strategy and confidence in the tech sector's ongoing expansion.

International Small-Mid Company Fund: Diversifying Globally

In Q2 2024, the Invesco International Small-Mid Company Fund provided investors with exposure to a diverse range of international small and mid-cap stocks. The fund's holdings spanned various countries and sectors, with a particular focus on Industrials and Consumer Discretionary 4

4

. This strategy aimed to capitalize on the growth potential of smaller companies in developed and emerging markets outside the United States.

Discovery Fund: Seeking Innovative Growth Opportunities

The Invesco Discovery Fund maintained its focus on identifying innovative companies with strong growth potential in Q2 2024. The fund's portfolio included a mix of established tech companies and emerging players in sectors such as biotechnology and renewable energy 5

5

. With a significant allocation to Information Technology and Health Care, the fund sought to benefit from technological advancements and breakthroughs in medical research.

Overall Performance and Market Trends

Across the reviewed Invesco funds, several common themes emerged in Q2 2024. Technology stocks continued to play a significant role in fund performance, with companies like Microsoft appearing as top holdings in multiple funds. The emphasis on dividend-paying stocks in some funds reflected a strategy to provide income stability in an uncertain economic environment.

The funds' diverse strategies catered to different investor preferences, from the income-focused Rising Dividends Fund to the growth-oriented Discovery Fund. International exposure through the Small-Mid Company Fund offered diversification benefits, while the Growth and Income Fund provided a balanced approach for more conservative investors.

Market trends influencing fund performance included ongoing technological innovation, global economic recovery efforts, and shifts in consumer behavior post-pandemic. The funds' sector allocations and stock selections reflected these trends, with many positioning themselves to capitalize on long-term growth opportunities while managing potential risks.